Advertisement

Centrally Mediated Cardiovascular Effects of Taurine

  • Katsuyuki Ando
  • Toshiro Fujita

Abstract

Taurine, which is synthesized from methionine in vivo, is a sulfur amino acid widely distributed in mammalian tissues, especially in brain, heart, and skeletal muscle. Taurine has been extensively studied for its cardiovascular actions. In stroke-prone spontaneously hypertensive rats (SHRSP) (Nara et al., 1978), spontaneously hypertensive rats (SHR) (Abe et al., 1987), and deoxycorticosterone acetate (DOCA)-salt hypertensive rats (Fujita and Sato, 1986; Inoue et al., 1988), the administration of taurine could attenuate the development of hypertension (Fig. 5.1). The antihypertensive effect of taurine is most pronounced in a salt-induced hypertensive model associated with increased sympathetic activity (Bouvier and de Champlain, 1986; Sato et al., 1991), such as the DOCA-salt rat (Fujita and Sato, 1986; Inoue et al., 1988). In addition, taurine has other cardiovascular actions, such as negative inotropic and positive chronotropic effects on heart (Huxtable and Sebring, 1982).

Keywords

Cold Exposure Sympathetic Nerve Activity Sympathetic Nervous System Activity Sulfur Amino Acid Endogenous Opioid Peptide 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Abe M, Shibata K, Matsuda T, Furukawa T (1987): Inhibition of hypertension and salt intake by oral taurine treatment in hypertensive rats. Hypertension 10:383–389Google Scholar
  2. Bousquet P, Feldman J, Bloch R, Schwartz J (1981): Central cardiovascular effects of taurine: Comparison with homotaurine and mucimol. J Pharmacol Exp Ther 219:213–218Google Scholar
  3. Bouvier M, de Champlain J (1986): Increased sympatho-adrenal tone and adrenal medulla reactivity in DOCA-salt hypertensive rats. J Hypertens 4:157–1CrossRefGoogle Scholar
  4. Brodie BB, Costa E, Dlabac A, Neff NH, Smookler HH (1966): Application of steady state kinetics to the estimation of synthesis rate and turnover time of tissue catecholamines. J Pharmacol Exp Ther 154:493–498Google Scholar
  5. Calaresu FR, Ciriello J (1981): Renal afferent nerves affect discharge rate of medullary and hypthalamic signal units in the cat. J Auton Nerv Syst 3:311–320CrossRefGoogle Scholar
  6. Cardenas HL, Ross DH (1976): Calcium depletion of synaptosomes after morphine treatment. Br J Pharmacol 57:521–526Google Scholar
  7. de Champlain J, Krakoff L, Axcelrod J (1969): Interrelationships of sodium intake, hypertension, and norepinephrine storage in the rat. Circ Res 24/25(Suppl I):75–92Google Scholar
  8. Einhorn D, Young JB, Landsberg L (1982): Hypotensive effect of fasting: possible involvement of the sympathetic nervous system and endogenous opiates. Science 217:727–729CrossRefGoogle Scholar
  9. Faden AI, Holaday JW (1979): Opiate antagonists: A role in the treatment of hypovolemic shock. Science 205:317–318CrossRefGoogle Scholar
  10. Falkner B, Onesti G, Angelakos T, Femandes M, Langman C (1979): Cardiovascular response to mental stress in normal adolescents with hypertensive parents: Hemodynamic and mental stress in adolescent. Hypertension 1:23–30Google Scholar
  11. Farsang C, Kaposci J, Juhasz I, Kunos G (1982): Possible involvement of an endogenous opioid in the antihypertensive effect of Clonidine in patients with essential hypertension. Circulation 66:1268–1272CrossRefGoogle Scholar
  12. Farsang C, Ramirez-Gonzales MD, Mucci L, Kunos G (1980): Possible role of an endogenous opiate in the cardiovascular effects of central α adrenoceptor stimulation in spontaneously hypertensive rats. J Pharmacol Exp Ther 214:203–208Google Scholar
  13. Fujita T, Ando K, Noda H, Ito Y, Sato Y (1987): Effects of increased adrenomedullary activity and taurine in young patients with borderline hypertension. Circulation 3:525–532CrossRefGoogle Scholar
  14. Fujita T, Ando K, Ogata E (1990): Systemic and regional hemodynamics in patients with salt-sensitive hypertension. Hypertension 16:235–244Google Scholar
  15. Fujita T, Noda H (1983): The hemodynamics in young patients with borderline hypertension. Jpn Circ J 47:795–801CrossRefGoogle Scholar
  16. Fujita T, Noda H, Ando K (1984): Sodium susceptibility and potassium effects in young patients with borderline hypertension. Circulation 69:468–476CrossRefGoogle Scholar
  17. Fujita T, Sato Y (1984): Changes in renal and central noradrenergic activity with potassium in DOCA-salt rats. Am J Physiol 246:F670–F675Google Scholar
  18. Fujita T, Sato Y (1986): Changes in blood pressure and extracellular fluid with taurine in DOCA-salt rats. Am J Physiol 250:R1014–R1020Google Scholar
  19. Fujita T, Sato Y (1988): Hypotensive effect of taurine: Possible involvement of the sympathetic nervous system and endogenous opiates. J Clin Invest 82:993–997CrossRefGoogle Scholar
  20. Fujita T, Sato Y, Ando K (1986): Changes in cardiac and hypothalamic noradrenergic activity with taurine in DOCA-salt rats. Am J Physiol 251:H926–H933Google Scholar
  21. Furukawa T, Yamada T, Kushiku K, Ono N, Tokunaga T (1982): Central effects of taurine: Antagonistic effects on central actions of angiotensin II. In: Taurine in Nutrition and Neurology, Huxtable RJ, Pasantes-Morales, eds. New York: Plenum, 345–359Google Scholar
  22. Glowinski J, Iversen LL (1966): The disposition of [3H]norepinephrine, [3H]dopamine, [3H]dopa in various regions of the brain. J Neurochem 13:655–669CrossRefGoogle Scholar
  23. Gordon R, Spector S, Sjoerdsma A, Udenfriend S (1966): Increased synthesis of norepinephrine and epinephrine in the intact rat during exercise and exposure to cold. J Pharmacol Exp Ther 153:440–447Google Scholar
  24. Guerrero-Munoz F, Guerrero ML, Way EL (1979): Effect of ß-endorphin on calcium uptake in the brain. Science 206:89–91CrossRefGoogle Scholar
  25. Haas HL, Hosli L (1973): The depression of brain stem neurons by taurine and its interaction with strychnine and bicuculline. Brain Res 52:399–402CrossRefGoogle Scholar
  26. Hardy JD, Hellon RF, Sutherland K (1964): Temperature-sensitive neurons in the dog’s hypothalamus. J Physiol 175:242–253Google Scholar
  27. Harris RA, Yamamoto H, Loh HH, Way EL (1977): Discrete changes in brain calcium with morphine analgesia, tolerance-dependence, and abstinence. Life Sci 20:501–506CrossRefGoogle Scholar
  28. Holaday JW, Faden AI (1978): Naloxone reversal of endotoxin hypotension suggests role of endorphin in shock. Nature 275:450–451CrossRefGoogle Scholar
  29. Horikoshi Y, Tajima I, Igarashi H, Inui M, Kasahara K, Noguchi T (1985): The adrenosympathetic system, the genetic predisposition to hypertension, and stress. Am J Med Sci 289:186–191CrossRefGoogle Scholar
  30. Huxtable RJ, Sebring L (1982): Cardiovascular actions of taurine. Sulfur Amino Acid 5:29–51Google Scholar
  31. Inoue A, Takahashi H, Lee L-C, Sasaki S, Kohno Y, Takeda K, Yoshimura M, Nakagawa M (1988): Retardation of the development of hypertension in DOCA salt rats by taurine supplement. Cardiovasc Res 22:351–358CrossRefGoogle Scholar
  32. Izumi K, Munekata E, Barbeau A, Nakanishi T, Yoneda M, Yamamoto H, Fukuda T (1982): Effects of taurine on tolerance to [D-Ala2, Met5] enkephalinamide in rats. Eur J Pharmacol 82:55–63CrossRefGoogle Scholar
  33. Izumi K, Munekata E, Yamamoto H, Nakanishi T, Barbeau A (1980): Effects of taurine and γ-aminobutyric acids on akinesia and analgesia induced by [D-Ala2, Met5] enkephalinamide in rats. Peptide 1:139–145Google Scholar
  34. Janssen HF, Lutherer LO (1980): Ventriculocisternal administration of naloxone protects against severe hypotension during endotoxin shock. Brain Res 194:608–612CrossRefGoogle Scholar
  35. Kunos G, Farsang C (1981): β-endorphin: Possible involvement in the antihypertensive effect of central α-receptor activation. Science 211:82–84CrossRefGoogle Scholar
  36. Kuriyama K (1980): Taurine as a neurotransmitter. Fed Proc 39:2680–2684Google Scholar
  37. Kuriyama K, Nakagawa K (1976): Role of taurine in adrenal gland: A preventive effects on stress-induced release of catecholamines from chromaffin granules. In: Taurine, Huxtable R, Barbeau A, eds. New York: Raven Press, 335–343Google Scholar
  38. Kuriyama K, Yoneda Y (1978): Morphine induced alterations of γ-aminobutyric acid and taurine contents and L-glutamate decarboxylase activity in rat spinal cord and thalamus: Possible correlates with analgesic action of morphine. Brain Res 148:163–179CrossRefGoogle Scholar
  39. Lundin S, Thoren P (1982): Renal function and sympathetic activity during mental stress in normotensive and spontaneously hypertensive rats. Acta Physiol Scand 115:115–124CrossRefGoogle Scholar
  40. Muramatsu M, Kakita K, Nakagawa K, Kuriyama K (1978): A modulating role of taurine on release of acetylcholine and norepinephrine from neuronal tissue. Jpn J Pharmacol 28:259–268CrossRefGoogle Scholar
  41. Nakamura K, Gerold M, Thoenen H (1971): Experimental hypertension of the rat: Reciprocal changes of norepinephrine turnover in heart and brain-stem. Naunnyn-Schmiedeberg’s Arch Pharmacol 268:125–139CrossRefGoogle Scholar
  42. Nara Y, Yamori Y, Lovenberg W (1978): Effects of dietary taurine on blood pressure in spontaneously hypertensive rats. Biochem Pharmacol 27:2689–2692CrossRefGoogle Scholar
  43. Niijima A (1981): Visceral afferents and metabolic function. Diabetologia 20:325–330CrossRefGoogle Scholar
  44. Patel KP, Ciriello J, Kline RL (1981): Noradrenergic mechanisms in brain and peripheral organs after aortic nerve transection. Am J Physiol 240:H481–H486Google Scholar
  45. Petty MA, de Jong W (1982): Cardiovascular effect of β-endorphin after microinjection into the nucleus tractus solitarii of the anaesthized rat. Eur J Pharmacol 81:449–457CrossRefGoogle Scholar
  46. Sato Y, Ando K, Fujita T (1987): Role of sympathetic nervous system in hypertensive action of taurine in DOCA-salt rats. Hypertension 9:81–87Google Scholar
  47. Sato Y, Ogata E, Fujita T (1991): Hypotensive action of taurine in DOCA-salt rats: Involvement of sympathoadrenal inhibition and endogenous opiate. Jpn Circ J 55:500–508CrossRefGoogle Scholar
  48. Shaw RK, Heine JD (1965): Ninhydrin positive substances present in different areas of normal rat’s brain. J Neurochem 12:151–155CrossRefGoogle Scholar
  49. Sitsen JMA, van Ree JM, de Jong W (1982): Cardiovascular and respiratory effects of β-endorphin in anesthetized and conscious rats. J Cardiovasc Pharmacol 4:883–888CrossRefGoogle Scholar
  50. Tedesco JL, Flattery KV, Sellers EA (1977): Effects of thyroid hormones and cold exposure on turnover of norepinephrine in cardiac and skeletal muscle. Can J Physiol Pharmacol 55:515–522CrossRefGoogle Scholar
  51. Tobey JC, Fry HK, Mizejewski CS, Fink GD, Weaver LC (1983): Differential sympathetic responses initiated by angiotensin and sodium chloride. Am J Physiol 245:R60–R68Google Scholar
  52. Yamamoto H, Harris RA, Loh H, Way EL (1978): Effects of acute and chronic morphine treatments on calcium localization and binding in brain. J Pharmacol Exp Ther 205:255–264Google Scholar
  53. Yamamoto H, McCain HW, Izumi K, Misawa S, Way EL (1981): Effects of amino acids, especially taurine and γ-aminobutyric acid (GABA), on analgesia and calcium depletion induced by morphine in mice. Eur J Pharmacol 71:177–184CrossRefGoogle Scholar
  54. Zeils R, Mansour EJ, Capone RJ, Mason DT (1974): The cardiovascular effects of morphine: The peripheral capacitance and resistance vessels in human subjects. J Clin Invest 54:1247–1258CrossRefGoogle Scholar

Copyright information

© Birkhäuser Boston 1992

Authors and Affiliations

  • Katsuyuki Ando
  • Toshiro Fujita

There are no affiliations available

Personalised recommendations